Bearssuckbutt
Posted - 5 hours ago
$BLUE last year this time it was over $4. now with 80 pts, more QTC, revenue rolling in, SCD act and its $.50. unbelievable. when in fact if and when big money and pharma realizes this is a Gem it be in $CRSP level. look in past how $OCGN and $SMMT rallied on rumors, hopes and phase trial results. this has 3 FDA approved gene therapies. $10 should be minimum BO
The_Dream_Team
Posted - 8 hours ago
$BLUE A buy signal was issued from a pivot bottom point on Friday, September 20, 2024, and so far it has risen 21.23%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
The_Dream_Team
Posted - 8 hours ago
$BLUE Since the stock is closer to the support from accumulated volume at $0.567 (0.47%) than the resistance at $0.692 (21.39%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
The_Dream_Team
Posted - 8 hours ago
$BLUE possible swing 18% Monday between high and low 👀
The_Dream_Team
Posted - 8 hours ago
$BLUE Trading Expectations (BLUE) For The Upcoming Trading Day Of Monday 7th
For the upcoming trading day on Monday, 7th we expect bluebird bio to open at $0.555, and during the day (based on 14 day Average True Range), to move between $0.516 and $0.624, which gives a possible trading interval of +/-$0.0541 (+/-9.50%) up or down from last closing price. If bluebird bio takes out the full calculated possible swing range there will be an estimated 18.99% move between the lowest and the highest trading price during the day.
Oowen
Posted - 9 hours ago
@coolelel @Gepram $blue has fda approved products, not just one, two i believe, i got out @$8 a couple of years ago, still lost over 60%.
jjpk
Posted - 9 hours ago
$BLUE am I reading correctly that these shower of cunts are giving themselves shares again. That couldn't be true
lzwa
Posted - 23 hours ago
$CRSP $VRTX $BLUE
https://www.reuters.com/business/healthcare-pharmaceuticals/why-gene-therapy-sickle-cell-is-slow-catch-with-patients-2024-09-28/
Oowen
Posted - 1 day ago
@Gepram there many bios like that, $ALLK , $BLUE, etc.
MsB_buyHighsellLow
Posted - 1 day ago
$BLUE BO for $5+
PennyConnection1
Posted - 1 day ago
$BLUE not a bad way to end week with a 10% day, see you all next week! Bottom seems to be in, can’t say the CEO can mess things up any further down here… but then again his track record says otherwise so 🤷♂️
HuntingBenjmins
Posted - 1 day ago
$BLUE When is the vote on the reverse split? What date?
Shad002
Posted - 1 day ago
$BLUE
BroadwayJoe12
Posted - 1 day ago
$BLUE I’m here now
JoeTheCheap
Posted - 1 day ago
$BLUE Praying hard for a weekend buyout at $3 or greater!!!
PennyConnection1
Posted - 1 day ago
$PRCH any of you porchers got any $BLUE lately ?
RoobinHood
Posted - 1 day ago
$BLUE
Garlic1969
Posted - 1 day ago
@Schizoo I'm in... $BLUE And maybe this conversation is the beginning of a beautiful friendship (Casablanca) !
Hahahaha
The_Dream_Team
Posted - 1 day ago
$BLUE I smell a poke in the eye over a buck soon. Anybody else smell that???
dkwast
Posted - 1 day ago
$BLUE high lows, let’s break that resistance
The_Dream_Team
Posted - 1 day ago
$BLUE Monday a run to .75 seems legit
blueb22
Posted - 1 day ago
$BLUE - One thing which is under wrap is what is going on with the CMS negotiations for OBA and Price for Lyfgenia, which has started in summer and had timeline to finish by mid-Nov. But that means BLUE will already know lot more details like how many states intending to enroll, how many patients they are intending to treat each year, what is the Price and all major terms of OBA by mid-October or at the most by end of October. We will not know those anytime soon, but potential buyers (large pharma) who are interested will know as soon as in next couple of week. And this is BIG piece of this whole Lyfgenia opportunity & potential puzzle. We are so close to this floodgates of new SCD patients who are under Medicaid coverage, and the whole intention of this CMS SCD roll-out in Jan2025 is to increase access to these two SCD gene therapies. Good Luck Longs! 👍 Fingers crossed 🤞
The_Dream_Team
Posted - 1 day ago
$BLUE
blueb22
Posted - 1 day ago
$BLUE - what I am looking forward to in Nov Q3 ER call: They are on target or exceeding the 40 patients starts in Q4 (there is no question or doubt that they will reach 40, but it could be that they could exceed that by 5) We know revenue will be low in Q3 (and also in Q4), so I am not worried if it is from 10 patients or from 7 patients infusions. In 2nd week of Nov they will be able to provide accurate Q4 start numbers as in 2nd half of December there will be hardly any new schedules for either cell collections or infusions. But, I am most interested in them providing numbers on how many are scheduled for cell collections in 2025 (or upto Q12025 to be more specific), as most of the new schedules now onwards would be for Q1 2025.
The_Dream_Team
Posted - 1 day ago
$BLUE I heard partnerships are coming
blueb22
Posted - 1 day ago
$BLUE - it brutal market like Yesterday's and today BLUE is up and is in consistent upward trend (no way it is pump and dump kind of move). This is good Sign. And I Think, Hope, and Pray that this slow upward trend will continue for weeks to come to reach the desired level of around $3-4.
Greedy_communist
Posted - 1 day ago
$BLUE easy folks, keep your risk in check with this one.
blueb22
Posted - 1 day ago
$BLUE - something may be in work like Royalty deal or ex-US deal (sale or partnership), and this 2nd is very much possible if they want to go that route as opposed to whole BO route. If they go one of these route, ofcourse they will be able to address the cash gap issue and may be even able to pay of Hercules debt (which I increasingly think they are planning to do).
Nikkosi
Posted - 1 day ago
$BLUE She on the move.
lasmanoz
Posted - 1 day ago
$BLUE whats going on here